AxoGen (AXGN) Reports In-Line Q2 EPS

AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.26 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
• AMC Entertainment launches tender offer for $360M in senior notes